author-photo

Sarah Kelly

University of Oxford

19

Papers

231

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

Persistence of Immunity Following 2-Dose Priming with a 10-Valent Pneumococcal Conjugate Vaccine at 6 and 10 Weeks or 6 and 14 Weeks of Age in Nepalese Toddlers.

2021 Pediatric Infectious Disease Journal
Show All
- Source
- Cite
- Save
Citations (0)
Childhood Invasive Bacterial Disease in Kathmandu, Nepal, 2005–2013

2021 Pediatric Infectious Disease Journal
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (4)
Differences in Immunization Site Pain in Toddlers Vaccinated with Either the 10- or the 13-Valent Pneumococcal Conjugate Vaccine

2018 Pediatric Infectious Disease Journal
Show All
- Source
- Cite
- Save
Citations (2)
Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial

2015 Lancet Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (17)
Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months

2015 Canadian Medical Association Journal
Show All
- Source
- Cite
- Save
Citations (24)
A cross-sectional observational study of pneumococcal carriage in children, their parents, and older adults following the introduction of the 7-valent pneumococcal conjugate vaccine.

2015 Medicine
Show All
- Source
- Cite
- Save
Citations (18)
Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementation.

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (11)
Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of age.

2014 Pediatric Infectious Disease Journal
Show All
- Source
- Cite
- Save
Citations (33)
Bactericidal antibody persistence 2 years after immunization with 2 investigational serogroup B meningococcal vaccines at 6, 8 and 12 months and immunogenicity of preschool booster doses: A follow-on study to a randomized clinical trial

2013 Pediatric Infectious Disease Journal
Show All
- Source
- Cite
- Save
Citations (38)